Intestinal Cell News Volume7.23 | Jun 25, 2021

    0
    34







    2021-06-25 | ICN 7.23


    Intestinal Cell News by STEMCELL Technologies
    Vol. 7.23 – 25 June, 2021
    TOP STORY

    Mechanical Compartmentalization of the Intestinal Organoid Enables Crypt Folding and Collective Cell Migration

    Scientists mapped 3D cellular forces in mouse intestinal organoids grown on soft hydrogels and showed that these organoids exhibited a non-monotonic stress distribution that defined mechanical and functional compartments.
    [Nature Cell Biology]

    AbstractPress Release

    Return to your lab safely and efficiently with these guides and resources so that you can focus more on moving your research goals forward.
    PUBLICATIONSRanked by the impact factor of the journal

    DHX15 Is Required to Control RNA Virus-Induced Intestinal Inflammation

    Researchers generated intestinal epithelial cell (IEC)-specific RNA helicase DEAH-box helicase 15 (DHX15)-knockout mice and demonstrated that DHX15 was required for controlling intestinal inflammation. Mechanistically, DHX15 interacted with NLRP6 to trigger NLRP6 inflammasome assembly and activation for inducing IL-18 secretion in IECs.
    [Cell Reports]

    Full ArticleGraphical Abstract

    LncRNA MIR17HG Promotes Colorectal Cancer Liver Metastasis by Mediating a Glycolysis-Associated Positive Feedback Circuit

    MIR17HG promoted glycolysis in colorectal cancer (CRC) cells and enhanced their invasion and liver metastasis in vitro and in vivo. Mechanistically, MIR17HG functioned as a ceRNA to regulate HK1 expression by sponging miR-138-5p, resulting in glycolysis in CRC cells and leading to their invasion and liver metastasis.
    [Oncogene]

    Full Article

    NF-κB-Activated SPRY4-IT1 Promotes Cancer Cell Metastasis by Downregulating TCEB1 mRNA via Staufen1-Mediated mRNA Decay

    The authors described the role of the long non-coding RNA SPRY4 intronic transcript 1 (SPRY4-IT1) in cancer metastasis by mechanisms related to Staufen1-mediated mRNA decay, and found that high SPRY4-IT1 expression was associated with aggressiveness and poor outcome in human colorectal, breast and ovarian cancer tissues.
    [Oncogene]

    Full Article

    Targeting Ribosomal G-Quadruplexes with Naphthalene-Diimides as RNA Polymerase I Inhibitors for Colorectal Cancer Treatment

    Scientists screened naphthalene-diimides, a class of guanine quadruplex (G4) ligands, in a cellular model of colorectal cancer, and identified the leading compound T5 with a potent and selective inhibition of cell growth by high-affinity binding to G4s in ribosomal DNA, impairing RNA polymerase I elongation.
    [Cell Chemical Biology]

    AbstractGraphical Abstract

    PCGF1 Promotes Epigenetic Activation of Stemness Markers and Colorectal Cancer Stem Cell Enrichment

    Investigators identified PCGF1 as a crucial epigenetic regulator that sustained the stem cell-like phenotype of colorectal cancer (CRC). PCGF1 knockdown inhibited CRC stem cell proliferation and CRC stem cell enrichment.
    [Cell Death & Disease]

    Full Article

    New Insights into the Mechanisms Underlying 5-Fluorouracil-Induced Intestinal Toxicity Based on Transcriptomic and Metabolomic Responses in Human Intestinal Organoids

    Well-established 3D organoid models of human colon and small intestine were used to characterize 5-Fluorouracil (5-FU) transcriptomic and metabolomic responses. Based on analysis of the differentially expressed genes, the most prominent molecular pathways affected by 5-FU included cell cycle, p53 signaling, mitochondrial ATP synthesis and apoptosis.
    [Archives of Toxicology]

    Full Article

    MicroRNA-766-3p-Mediated Downregulation of HNF4G Inhibits Proliferation in Colorectal Cancer Cells through the PI3K/AKT Pathway

    The authors investigated the role nuclear receptors played in colorectal cancer (CRC) pathogenesis. Overexpression of hepatocyte nuclear factor 4 gamma (HNF4G) significantly promoted the proliferation of CRC cells in vitro.
    [Cancer Gene Therapy]

    Abstract

    PD-L1 Upregulation Is Associated with Activation of the DNA Double-Strand Break Repair Pathway in Patients with Colitic Cancer

    Researchers investigated the significance of the PD-L1/double-strand break repair pathway using samples from 17 sporadic colorectal cancer and ulcerative colitis (UC) patients with rare UC-associated dysplasia/colitic cancer cases by immunohistochemical analysis.
    [Scientific Reports]

    Full Article

    Hypoxia and Heat Stress Affect Epithelial Integrity in a Caco-2/HT-29 Co-Culture

    Scientists developed an in vitro intestinal monolayer model using two human colonic epithelial cell lines, Caco-2 and HT-29, co-cultured in Transwell inserts and investigated the effects of heat treatment and/or hypoxia on the epithelial barrier function.
    [Scientific Reports]

    Full Article

    Egr-1 Inhibits Colon Cancer Cell Proliferation, Migration and Invasion via Regulating CDKL1 at the Transcriptional Level

    Overexpression of Egr‑1 inhibited colon cancer cell proliferation, migration, and invasion, whereas knockdown of Egr‑1 increased colon cancer cell proliferation, migration and invasion.
    [Oncology Reports]

    Abstract

    Hepcidin Sequesters Iron to Sustain Nucleotide Metabolism and Mitochondrial Function in Colorectal Cancer Epithelial Cells

    Researchers found that iron chelation decreased mitochondrial function, thereby altering nucleotide synthesis, whereas exogenous supplementation of nucleosides or aspartate partially rescued tumor growth in patient-derived enteroids and colorectal cancer cell lines in the presence of an iron chelator.
    [Nature Metabolism]

    Abstract

    Explore Antibodies for Epithelial Cell Markers
    REVIEWS

    Inflammatory Adaptation in Barrier Tissues

    Investigators review the cellular communication networks in barrier tissues and the integration between tissue-resident and recruited immune cells and tissue stem cells underlying tissue adaptation to environmental stress.
    [Cell]

    Full Article

    Hypoxia and HIF-1 as Key Regulators of Gut Microbiota and Host Interactions

    The authors discuss recent evidence suggesting that the intricate and multidirectional interactions among the microbiota, hypoxia/hypoxic sensors, and mammalian host cells determine how the intestinal barrier and host-microbiota-pathogens connections are molded.
    [Trends in Immunology]

    Abstract

    Personalised Medicine: Stem Cells in Colorectal Cancer Treatment

    Scientists point out the dynamic potential of cancer stem cells and other stem cell types in colorectal cancer (CRC) treatment personalization as well as, in the improvement of current treatment approaches, opting for a higher therapeutic rate, improved prognosis, survival, and quality of life for CRC patients.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    INDUSTRY AND POLICY NEWS

    Amneal Announces US FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab

    Amneal Pharmaceuticals, Inc. announced the US FDA has accepted for review the Biologics License Application for Bevacizumab. Amneal is seeking approval for Bevacizumab for the treatment of metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment.
    [Amneal Pharmaceuticals, Inc.]

    Press Release

    Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (Nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

    Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approval of Opdivo for the adjuvant treatment of adult patients with esophageal or gastroesophageal junction cancer who have residual pathologic disease following prior neoadjuvant chemoradiotherapy.
    [Bristol Myers Squibb]

    Press Release

    FEATURED EVENT

    Origins of Cancer

    July 22 – 23, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Positions – Cellular, Molecular and Digital Medicine

    Research Center for Molecular Medicine – Vienna, Austria

    Research Associate – p53-Microbiome Axis in Intestinal Cancer

    The Hebrew University of Jerusalem – Jerusalem, Israel

    Postdoctoral Fellow – Precision Oncology of Gastrointestinal Cancers

    City of Hope – Monrovia, California, United States

    Postdoctoral Fellow – Gut Metabolites in Organoid Infection Models

    Uppsala University – Uppsala, Sweden

    Postdoctoral Research Associate – Gastrointestinal Pathophysiology

    University of Maryland, College Park – College Park, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter